Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00409214
Status:
COMPLETED
Last Update Posted:
2012-11-16
First Post:
2006-12-07
Brief Title:
Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or RecurrentHigh-grade Glioma Using the Litx System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
Sponsor:
Organization:
Light Sciences Oncology
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
18
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: